The SUger Blend

Elixir is redefining energy drinks with 10g of allulose, a plant-based sweetener that offers zero glycemic impact and scientifically proven benefits. Allulose activates GLP-1, a hormone that regulates appetite and supports metabolic health, helping you feel in control of your cravings.

Studies show that allulose not only satisfies your sweet tooth without spiking blood sugar but also aids in promoting weight loss when paired with a healthy lifestyle. With Elixir, you’re not just getting energy—you’re fueling your greatness while supporting your wellness goals.

Allulose

The Secret Ingredient
for Weight Loss

----------------------

Hayashi et al. (2010):

In a randomized, double-blind, placebo-controlled trial with healthy adults, participants consumed 5 g of allulose or a placebo three times daily for 12 weeks. The study found that the allulose group had a significant reduction in body weight and body fat mass compared to the placebo group. 

 

Han et al. (2018) 

Conducted a randomized, double-blind, placebo-controlled trial with 121 overweight/obese Korean adults. Participants were divided into placebo, low-dose allulose (4 g twice daily), and high-dose allulose (7 g twice daily) groups. The study found that both body fat percentage and body fat mass significantly decreased in the allulose groups. The high-dose allulose group also showed significant reductions in BMI and abdominal fat areas compared to the placebo group. 

 

Kimura et al. (2017):

This study involved 13 healthy participants in a randomized, single-blind crossover design. Participants ingested 5 g of allulose or a control (aspartame) before a standardized meal. The study found that allulose enhanced postprandial fat oxidation, which increases energy expenditure. 

 

Activates GLP-1 and Suppresses Appetite

------------------------

Teysseire et al. (2022)

Conducted a randomized, controlled, double-blind, crossover study with participants who received 25g allulose. Allulose was found to stimulate the secretion of GI satiation hormones CCK, GLP-1, and PYY in humans.

 

Hayakawa et al. (2018)

A study in mice showed that intracerebroventricular injection of allulose inhibited food intake by activating anorexigenic neurons in the hypothalamic arcuate nucleus (ARC), including those responsive to GLP-1 and expressing proopiomelanocortin (POMC).

 

Bikman et al. (2024)

Found that that allulose supplementation can improve metabolic health markers, making it a promising dietary component for managing obesity and T2D. 

Blood Sugar Control

----------------------

Noronha et al. (2018)

Conducted a double-blind, randomized, controlled, acute feeding trial in 24 participants with type 2 diabetes. The study found that allulose significantly reduced the plasma glucose incremental area under the curve (iAUC) by 8% at a 10 g dose compared to the control (0 g).

 

Fukunaga et al. (2023)

Performed a prospective, randomized, single-blind, crossover study in patients with type 2 diabetes. The study showed that a diabetic diet containing 8.5 g of allulose improved postprandial blood glucose (PPG) levels compared to a standard diabetic diet.

 

Yuma et al. (2023)

Performed a systematic review and meta-analysis, which included studies on healthy humans. The analysis showed that both 5 g and 10 g doses of allulose significantly reduced the area under the curve (AUC) of postprandial blood glucose levels.

ingredients Studies

  • 01

  • A Preliminary Study for Evaluating the Dose-Dependent Effect of D-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.

    Han Y, Kwon EY, Yu MK, et al. 

    Nutrients. 2018;10(2):E160. doi:10.3390/nu10020160. 

    View Study 

  • 02

  • 12-week continuous ingestion of D-allulose in borderline diabetes and type 2 diabetes

    Hayashi N, Tanaka M, et al.

    The Journal of Fundamental Tox Sciences. 2019. Volume 6 Issue 6 Pages 225-234https://doi.org/10.2131/fts.6.225

    View Study 

  • 03

  • D-Allulose Enhances Postprandial Fat Oxidation in Healthy Humans

    Kimura T, Kanasaki A, Hayashi N, et al.

    Nutrition (Burbank, Los Angeles County, Calif.).

    2017 Nov - Dec; 43-44:16-20. DOI: 10.1016/j.nut.2017.06.007

    View Study 

  • 04

  • The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial

    Teysseire F, Bordier V, Budzinska A, et al.

    The Journal of Nutrition.2022;152(5):1228-1238. doi:10.1093/jn/nxac026.

    View Study 

  • 05

  • Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats

    Hayakawa M, Hira T, Nakamura M, et al.

    Biochemical and Biophysical Research Communications. 2018;:S0006-291X(18)30143-8.

    doi:10.1016/j.bbrc.2018.01.128.

    View Study 

  • 06

  • The Metabolic and Endocrine Effects of a 12-Week Allulose-Rich Diet

    Bikman BT et al.

    Nutrients. 2024 Jun 10;16(12):1821.

    doi: 10.3390/nu16121821.

    PMID: 38931176; PMCID: PMC11207032.

    View Study 

  • 07

  • The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial

    Noronha JC, Braunstein CR, Glenn AJ, et al. 

    Diabetes, Obesity & Metabolism. 2018;20(10):2361-2370.

    doi:10.1111/dom.13374. 

    View Study 

  • 08

  • A Pilot Study on the Efficacy of a Diabetic Diet Containing the Rare Sugar D-Allulose in Patients with Type 2 Diabetes Mellitus: A Prospective, Randomized, Single-Blind, Crossover Study

    Fukunaga K, Yoshimura T, Imachi H, et al. 

    Nutrients. 2023;15(12):2802.

    doi:10.3390/nu15122802. 

    View Study 

  • 09

  • Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis

    Yuma T, Tokuda M, Nishimoto N, Yokoi H, Izumori K.

    PloS One. 2023;18(4):e0281150.

    doi:10.1371/journal.pone.0281150.

    View Study